- Tumor-Targeted Delivery of 6-Diazo-5-oxo-L-norleucine (DON) Using Substituted Acetylated Lysine ProdrugsPublication without faculty affiliation
- Graft HPMA copolymer conjugates for passive tumor targetingPublication without faculty affiliation
- Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting2008 | First Faculty of Medicine
- Tumor-targeted drug delivery based on HPMA: basic principles for design and transfer from the laboratory to clinicPublication without faculty affiliation
- The effect of chelator type on in vitro receptor binding and stability in Lu-177-labeled cetuximab and panitumumab2014 | Faculty of Pharmacy in Hradec Králové
- Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors2021 | Faculty of Medicine in Hradec Králové
- Comparison of 111In-DOTA-NOC and 111In-DOTA-TATE distribution in the target and dose-limiting tissues: conflicting results in vitro and in vivo2008 | Central Library of Charles University
- Trial Watch-Immunostimulation with cytokines in cancer therapy2016 | Second Faculty of Medicine
- Targeted Polymer-Based Probes for Fluorescence Guided Visualization and Potential Surgery of EGFR-Positive Head-and-Neck Tumors2020 | First Faculty of Medicine
- Trigeminal Neuralgia Secondary to Meningiomas and Vestibular Schwannoma Is Improved after Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis2021 | First Faculty of Medicine
- Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-l-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery2023 | Faculty of Science, Central Library of Charles University
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy2016 | Second Faculty of Medicine
- Trial Watch-Oncolytic viruses and cancer therapy2016 | Second Faculty of Medicine
- Paclitaxel Derivatives for Targeted Delivery to Cancer Cells2010 | Faculty of Science
- Antitumor activity of apoptotic nuclease TBN1 from L. esculentum.2010 | First Faculty of Medicine
- Targeted nanoparticles - a promising opportunity in cancer therapy - Review2016 | Faculty of Science, Second Faculty of Medicine
- Trial watch: Naked and vectored DNA-based anticancer vaccines2015 | Second Faculty of Medicine
- Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities2019 | Second Faculty of Medicine
- Modern treatment of non-small cell lung carcinoma2017 | Faculty of Medicine in Pilsen
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications2015 | Second Faculty of Medicine
- Classification of current anticancer immunotherapies2014 | Second Faculty of Medicine
- Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer2015 | Second Faculty of Medicine
- Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy2018 | Second Faculty of Medicine
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells2021 | Second Faculty of Medicine
- Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with α-ketoamide warheads2021 | Faculty of Science, Central Library of Charles University, Faculty of Physical Education and Sport
- Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with alpha-ketoamide warheads2021 | Faculty of Science, Central Library of Charles University, Faculty of Physical Education and Sport
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death2015 | Second Faculty of Medicine
- Detection of immunogenic cell death and its relevance for cancer therapy2020 | Second Faculty of Medicine
- Hpma-based copolymers carrying stat3 inhibitor cucurbitacin-d as stimulus-sensitive nanomedicines for oncotherapy2021 | Central Library of Charles University
- Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.Publication without faculty affiliation